Nippon Shinyaku

Company typePublic (K.K)^[1][2]

IndustryPharmaceuticals, Functional Foods^[1][2][3]

FoundedOctober 1, 1919; 106 years ago (1919-10-01) in Kyoto, Japan^[2]

Headquarters

Kyoto [2][1][5]^[1][2][4]

,

Japan^[1][2][4]

Nippon Shinyaku

Nippon Shinyaku Head Office Exterior - Nishioji Street
Company type	Public (K.K)[1][2]
Industry	Pharmaceuticals, Functional Foods[1][2][3]
Founded	October 1, 1919; 106 years ago (1919-10-01) in Kyoto, Japan[2]
Headquarters	Kyoto [2][1][5][1][2][4] , Japan[1][2][4]
Area served	Worldwide[1][2][3]
Key people	Toru Nakai (President), Shigenobu Maekawa (Chairman), Takashi Takaya (Director), Kazuchika Takagaki (Director, Head R&D) [2][6][7][8]
Products	Prescription drugs, functional foods[1][2]
Number of employees	2,243[2][4][5] (2025[2][5])
Website	www.nippon-shinyaku.co.jp/english/[1][2]

Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that develops, manufactures, and markets prescription drugs and functional foods. Founded in 1911, the company initially focused on herbal medicines before expanding into modern pharmaceuticals, with current therapeutic areas including urology, hematology, intractable and rare diseases, and gynecology.^[6] Nippon Shinyaku is listed on the Tokyo Stock Exchange and has developed treatments such as viltolarsen for Duchenne muscular dystrophy.^[7]